April L. Ferre, Ph.D. - Publications

Affiliations: 
2010 University of California, Davis, Davis, CA 
Area:
Microbiology Biology, Immunology

16 high-probability publications. We are testing a new system for linking publications to authors. You can help! If you notice any inaccuracies, please sign in and mark papers as correct or incorrect matches. If you identify any major omissions or other inaccuracies in the publication list, please let us know.

Year Citation  Score
2023 Omidvari N, Jones T, Price PM, Ferre AL, Lu J, Abdelhafez YG, Sen F, Cohen SH, Schmiedehausen K, Badawi RD, Shacklett BL, Wilson I, Cherry SR. First-in-human immunoPET imaging of COVID-19 convalescent patients using dynamic total-body PET and a CD8-targeted minibody. Science Advances. 9: eadh7968. PMID 37824612 DOI: 10.1126/sciadv.adh7968  0.632
2023 Omidvari N, Jones T, Price PM, Ferre AL, Lu J, Abdelhafez YG, Sen F, Cohen SH, Schmiedehausen K, Badawi RD, Shacklett BL, Wilson I, Cherry SR. First-in-human immunoPET imaging of COVID-19 convalescent patients using dynamic total-body PET and a CD8-targeted minibody. Medrxiv : the Preprint Server For Health Sciences. PMID 36993568 DOI: 10.1101/2023.03.14.23287121  0.613
2021 SenGupta D, Brinson C, DeJesus E, Mills A, Shalit P, Guo S, Cai Y, Wallin JJ, Zhang L, Humeniuk R, Begley R, Geleziunas R, Mellors J, Wrin T, Jones N, ... ... Ferre AL, et al. The TLR7 agonist vesatolimod induced a modest delay in viral rebound in HIV controllers after cessation of antiretroviral therapy. Science Translational Medicine. 13. PMID 34162752 DOI: 10.1126/scitranslmed.abg3071  0.654
2020 Shacklett BL, Ferre AL, Kiniry BE. Defining T Cell Tissue Residency in Humans: Implications for HIV Pathogenesis and Vaccine Design. Current Hiv/Aids Reports. PMID 32052270 DOI: 10.1007/S11904-020-00481-7  0.695
2019 Shacklett BL, Ferre AL, Kiniry BE. Tissue issues: mucosal T-cell responses in HIV-1 infection. Current Opinion in Hiv and Aids. 14: 100-107. PMID 30601239 DOI: 10.1097/Coh.0000000000000530  0.735
2018 Hughes SM, Ferre AL, Yandura SE, Shetler C, Baker CAR, Calienes F, Levy CN, Astronomo RD, Shu Z, Lentz GM, Fialkow M, Kirby AC, McElrath MJ, Sinclair E, Rohan LC, et al. Cryopreservation of human mucosal tissues. Plos One. 13: e0200653. PMID 30059507 DOI: 10.1371/Journal.Pone.0200653  0.591
2016 Hughes SM, Shu Z, Levy CN, Ferre AL, Hartig H, Fang C, Lentz G, Fialkow M, Kirby AC, Adams Waldorf KM, Veazey RS, Germann A, von Briesen H, McElrath MJ, Dezzutti CS, et al. Cryopreservation of Human Mucosal Leukocytes. Plos One. 11: e0156293. PMID 27232996 DOI: 10.1371/Journal.Pone.0156293  0.663
2016 Ganesh A, Lemongello D, Lee E, Peterson J, McLaughlin B, Ferre AL, Gillespie G, Fuchs D, Deeks SG, Hunt PW, Price RW, Spudich S, Shacklett BL. Immune Activation and HIV-Specific CD8+ T-cells in Cerebrospinal Fluid of HIV Controllers and Non-Controllers. Aids Research and Human Retroviruses. PMID 27019338 DOI: 10.1089/Aid.2015.0313  0.763
2014 Serrano-Villar S, Sainz T, Lee SA, Hunt PW, Sinclair E, Shacklett BL, Ferre AL, Hayes TL, Somsouk M, Hsue PY, Van Natta ML, Meinert CL, Lederman MM, Hatano H, Jain V, et al. HIV-infected individuals with low CD4/CD8 ratio despite effective antiretroviral therapy exhibit altered T cell subsets, heightened CD8+ T cell activation, and increased risk of non-AIDS morbidity and mortality. Plos Pathogens. 10: e1004078. PMID 24831517 DOI: 10.1371/Journal.Ppat.1004078  0.667
2013 Hatano H, Yukl SA, Ferre AL, Graf EH, Somsouk M, Sinclair E, Abdel-Mohsen M, Liegler T, Harvill K, Hoh R, Palmer S, Bacchetti P, Hunt PW, Martin JN, McCune JM, et al. Prospective antiretroviral treatment of asymptomatic, HIV-1 infected controllers. Plos Pathogens. 9: e1003691. PMID 24130489 DOI: 10.1371/Journal.Ppat.1003691  0.713
2011 Shacklett BL, Ferre AL. Mucosal immunity in HIV controllers: the right place at the right time. Current Opinion in Hiv and Aids. 6: 202-7. PMID 21399497 DOI: 10.1097/Coh.0B013E3283453E2B  0.722
2010 Ferre AL, Hunt PW, McConnell DH, Morris MM, Garcia JC, Pollard RB, Yee HF, Martin JN, Deeks SG, Shacklett BL. HIV controllers with HLA-DRB1*13 and HLA-DQB1*06 alleles have strong, polyfunctional mucosal CD4+ T-cell responses. Journal of Virology. 84: 11020-9. PMID 20719952 DOI: 10.1128/Jvi.00980-10  0.756
2010 Ferre AL, Lemongello D, Hunt PW, Morris MM, Garcia JC, Pollard RB, Yee HF, Martin JN, Deeks SG, Shacklett BL. Immunodominant HIV-specific CD8+ T-cell responses are common to blood and gastrointestinal mucosa, and Gag-specific responses dominate in rectal mucosa of HIV controllers. Journal of Virology. 84: 10354-65. PMID 20668079 DOI: 10.1128/Jvi.00803-10  0.759
2009 Ferre AL, Hunt PW, Critchfield JW, Young DH, Morris MM, Garcia JC, Pollard RB, Yee HF, Martin JN, Deeks SG, Shacklett BL. Mucosal immune responses to HIV-1 in elite controllers: a potential correlate of immune control. Blood. 113: 3978-89. PMID 19109229 DOI: 10.1182/Blood-2008-10-182709  0.756
2009 Shacklett BL, Critchfield JW, Ferre AL, Hayes TL. Mucosal T-cell responses to HIV: responding at the front lines. Journal of Internal Medicine. 265: 58-66. PMID 19093960 DOI: 10.1111/J.1365-2796.2008.02042.X  0.763
2008 Emu B, Sinclair E, Hatano H, Ferre A, Shacklett B, Martin JN, McCune JM, Deeks SG. HLA class I-restricted T-cell responses may contribute to the control of human immunodeficiency virus infection, but such responses are not always necessary for long-term virus control Journal of Virology. 82: 5398-5407. PMID 18353945 DOI: 10.1128/Jvi.02176-07  0.734
Show low-probability matches.